Nouvelles Eulerpool Cosmo Pharmaceuticals

Eulerpool-AFX Cosmo Pharmaceuticals

Cosmo Pharmaceuticals Actualités des actions

Cosmo Pharmaceuticals est surveillé par de nombreux journalistes et investisseurs du monde entier. Nous regroupons ici les dernières actualités Cosmo Pharmaceuticals.

• 23 septembre ·

  Yahoo
  Cosmo Pharmaceuticals Enhances Management Team with Newly Appointed Head of Global Business Development
• 2 septembre ·

  Yahoo
  Cosmo Pharmaceuticals Highlights Study Published in "The Lancet" Demonstrating the Efficacy of GI Genius(TM) in Colonoscopy Procedures
• 31 juillet ·

  Yahoo
  Cosmo Intelligent Medical Devices Unveils Next Generation GI Genius(TM) Hardware with New FDA Clearance
• 24 juillet ·

  Yahoo
  Cosmo Achieves Robust Financial Performance in H1 2024 and Confirms Its Full Year Guidance
• 9 juillet ·

  Yahoo
  Invitation to Cosmo's Half-Year 2024 Webcast on 24 July 2024
• 5 juillet ·

  Yahoo
  Cosmo Shareholders Approved All Resolutions Proposed by the Board of Directors at Extraordinary General Meeting
• 18 juin ·

  Yahoo
  Cosmo's Oral Diagnostic Drug Lumeblue(R) Receives Approval of New Drug Application in China
• 3 juin ·

  Yahoo
  Cosmo to Bring Real-Time AI into Intelligent Medical Devices with NVIDIA IGX
• 1 juin ·

  Yahoo
  Cosmo Reports Excellent Final Full Year 2023 Financial Results - Increases Operating Profit Guidance for 2024 - Dividend of 2.00 per Share Will Be Proposed at EGM on 5 July 2024
• 24 mai ·

  Yahoo
  Cosmo Pharmaceuticals' Shareholders Approve All Agenda Items at Annual General Meeting